102918 Federal Register / Vol. 89, No. 243 / Wednesday, December 18, 2024 / Notices 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Environmental Health Sciences Special 

Emphasis Panel: Mechanism for TimeSensitive Research Opportunities in 

Environmental Health Sciences (R21). 

Date: January 15, 2025. 

Time: 11:30 a.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institute of 

Environmental Health Sciences, Keystone 

Building, 530 Davis Drive, Durham, NC 

27709. 

Meeting Format: Virtual Meeting. 

Contact Person: Murali Ganesan, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Research and 

Training (DERT), National Institute of 

Environmental Health Sciences, National 

Institutes of Health, Keystone Building, 

Room 3097, Research Triangle Park, NC 

27713, Phone: 984–287–4674, Email: 

murali.ganesan@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.115, Biometry and Risk 

Estimation—Health Risks from 

Environmental Exposures; 93.142, NIEHS 

Hazardous Waste Worker Health and Safety 

Training; 93.143, NIEHS Superfund 

Hazardous Substances—Basic Research and 

Education; 93.894, Resources and Manpower 

Development in the Environmental Health 

Sciences; 93.113, Biological Response to 

Environmental Health Hazards; 93.114, 

Applied Toxicological Research and Testing, 

National Institutes of Health, HHS) 

Dated: December 12, 2024. 

Bruce A. George, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–29836 Filed 12–17–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Deafness and 

Other Communication Disorders; 

Notice of Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; EarlyStage Dissemination and Implementation 

Research in Communication Disorders. 

Date: January 16, 2025. 

Time: 12:30 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. 

Meeting Format: Virtual Meeting. 

Contact Person: Andrea B. Kelly, Ph.D., 

Scientific Review Officer, National Institute 

on Deafness and Other Communication 

Disorders, National Institutes of Health, 6001 

Executive Boulevard, Room 8351, Bethesda, 

MD 20892, (301) 451–6339, kellya2@nih.gov. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; Inner Ear 

Imaging RFA Review. 

Date: January 30, 2025. 

Time: 1:30 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. 

Meeting Format: Virtual Meeting. 

Contact Person: Kausik Ray, Ph.D., 

Scientific Review Officer, National Institute 

on Deafness and Other Communication 

Disorders, National Institutes of Health, 6001 

Executive Blvd., Rockville, MD 20852, 301– 

402–3587, rayk@nidcd.nih.gov. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; NIDCD 

Institutional Research Training Opportunities 

Review. 

Date: January 31, 2025. 

Time: 1:00 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. 

Meeting Format: Virtual Meeting. 

Contact Person: Andrea B. Kelly, Ph.D., 

Scientific Review Officer, National Institute 

on Deafness and Other Communication 

Disorders, National Institutes of Health, 6001 

Executive Boulevard, Room 8351, Bethesda, 

MD 20892, (301) 451–6339, kellya2@nih.gov. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; NIDCD 

Clinical Research Center Grant (P50) Review. 

Date: February 6, 2025. 

Time: 1:00 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. 

Meeting Format: Virtual Meeting. 

Contact Person: Kausik Ray, Ph.D., 

Scientific Review Officer, National Institute 

on Deafness and Other Communication 

Disorders, National Institutes of Health, 6001 

Executive Blvd., Rockville, MD 20852, 301– 

402–3587, rayk@nidcd.nih.gov. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; 

Chemosensory Fellowship Review Meeting. 

Date: February 11, 2025. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. 

Meeting Format: Virtual Meeting. 

Contact Person: Sonia Elena Nanescu, 

Ph.D., Scientific Review Officer, Division of 

Extramural Activities, NIDCD, NIH, 6001 

Executive Blvd., Suite 8300, Bethesda, MD 

20892, (301) 496–8683, sonia.nanescu@

nih.gov. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; Hearing 

and Balance Fellowship Review. 

Date: February 21, 2025. 

Time: 12:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: Hilton Garden Inn Seaworld 

Orlando, FL. 

Meeting Format: Virtual Meeting. 

Contact Person: Martin Basch, Ph.D., 

Scientific Review Officer, NIH/NIDCD, 

Scientific Review Branch, 6001 Executive 

Blvd., Suite 8300, Bethesda, MD 20892, (301) 

496–9693, martin.basch@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.173, Biological Research 

Related to Deafness and Communicative 

Disorders, National Institutes of Health, HHS) 

Dated: December 12, 2024. 

Victoria E. Townsend, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–29910 Filed 12–17–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; HEAL 

Initiative: Translating Research to Practice to 

End the Overdose Crisis. 


khammond on DSK9W7S144PROD with NOTICES
Federal Register / Vol. 89, No. 243 / Wednesday, December 18, 2024 / Notices 102919 

Date: January 23–24, 2025. 

Time: 10:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institute of Health 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Sheila Pirooznia, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Review, 

National Institute on Drug Abuse, NIH, 301 

North Stonestreet Avenue, MSC 6021, 

Bethesda, MD 20892, (301) 496–9350, 

sheila.pirooznia@nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; NIDA 

REI: Research at Minority Serving 

Institutions on Neurocognitive Mechanisms 

Underlying the Impact of Structural Racism 

on the Substance Use Trajectory. 

Date: February 3, 2025. 

Time: 3:00 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institute of Health 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Shareen Amina Iqbal, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, Division of Extramural 

Research, National Institute on Drug Abuse, 

NIH, 301 North Stonestreet Avenue, MSC 

6021, Bethesda, MD 20892, (301) 443–4577, 

shareen.iqbal@nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Developing Digital Therapeutics for 

Substance Use Disorders. 

Date: February 5, 2025. 

Time: 1:00 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institute of Health 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Shareen Amina Iqbal, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, Division of Extramural 

Research, National Institute on Drug Abuse, 

NIH, 301 North Stonestreet Avenue, MSC 

6021, Bethesda, MD 20892, (301) 443–4577, 

shareen.iqbal@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.277, Drug Abuse Scientist 

Development Award for Clinicians, Scientist 

Development Awards, and Research Scientist 

Awards; 93.278, Drug Abuse National 

Research Service Awards for Research 

Training; 93.279, Drug Abuse and Addiction 

Research Programs, National Institutes of 

Health, HHS) 

Dated: December 12, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–29831 Filed 12–17–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

The National Institutes of Health Public 

Access Policy 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: The 2024 National Institutes 

of Health (NIH) Public Access Policy 

implements additional steps to 

accelerate free public access to scholarly 

publications resulting from the research 

that NIH supports, building upon NIH’s 

long history of providing public access 

to research results. 

FOR FURTHER INFORMATION CONTACT: 

Hilary Leeds, J.D., Senior Policy Analyst 

for Public Access, Office of Science 

Policy, at (301) 496–9838 or 

SciencePolicy@od.nih.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

Increasing access to publications 

resulting from the National Institutes of 

Health (NIH) funding offers many 

benefits to the scientific community and 

the public who funded the underlying 

research. When patients, families, and 

healthcare providers can access 

published findings resulting from NIH 

funding, they are able to better 

understand and address the most 

critical health concerns facing their 

communities. It also allows researchers, 

students, and members of the public in 

all communities to have equitable 

access to such content. This access can 

accelerate future research, lead to 

collaboration, and allow interested 

readers and patients to follow the latest 

advances more closely. Importantly, 

these goals reflect NIH’s commitment to 

the responsible stewardship of the 

Nation’s investment in biomedical 

research by improving transparency and 

accessibility of taxpayer-funded 

research, an essential component of 

fostering trust in research. NIH is 

issuing this updated Public Access 

Policy to further advance these goals by 

accelerating free public access to 

research results. 

NIH has a long history of providing 

access to research products resulting 

from its funded research. The NIH 

Public Access Policy https://

sharing.nih.gov/public-access-policy/ 

public-access-policy-overview in effect 

since 2008, requires that NIH-supported 

researchers submit their final peerreviewed manuscripts to the National 

Library of Medicine’s PubMed Central®

digital archive of full-text biomedical 

and life sciences journal literature upon 

acceptance for publication, to be made 

freely available to the public after an 

allowable embargo period of not more 

than 12 months after the official date of 

publication. The 2008 Policy 

implements Public Law 110–161 

https://www.congress.gov/110/statute/ 

STATUTE-121/STATUTE-121- 

Pg1844.pdf, which was made a 

legislative mandate for FY 2009 and 

beyond by Public Law 111–8 https://

www.govinfo.gov/content/pkg/PLAW111publ8/pdf/PLAW-111publ8.pdf. The 

Policy has, to date, resulted in more 

than 1.5 million articles reporting on 

NIH-supported research being freely 

available to the public in PubMed 

Central. 

On August 25, 2022, the White House 

Office of Science and Technology Policy 

(OSTP) released updated policy 

guidance (2022 OSTP Memorandum 

https://www.whitehouse.gov/wpcontent/uploads/2022/08/08-2022- 

OSTP-Public-Access-Memo.pdf) to all 

federal agencies with research and 

development expenditures to further 

promote equity, advance trust in 

science, and continue to advance 

American scientific leadership. 

Following the 2022 OSTP 

Memorandum, NIH released its Plan to 

Enhance Public Access to the Results of 

NIH-Supported Research https://

grants.nih.gov/grants/guide/notice-files/ 

NOT-OD-23-091.html in February 2023 

(hereafter, the NIH Public Access Plan) 

and its Draft Public Access Policy 

https://www.federalregister.gov/ 

documents/2024/06/18/2024-13373/ 

request-for-information-on-the-nationalinstitutes-of-health-draft-public-accesspolicy in June 2024 (NIH Draft Public 

Access Policy). The NIH Public Access 

Plan and Draft Public Access Policy 

provided a roadmap for how NIH 

proposed to accelerate access to 

scholarly publications, consistent with 

the government-wide expectation to 

remove the 12-month embargo period 

before public availability. This 2024 

NIH Public Access Policy is consistent 

with the expectations of the 2022 OSTP 

Memorandum regarding scholarly 

publications and is informed by all 

public feedback, including comments 

submitted in response to the NIH Draft 

Public Access Policy. 

Overview of Public Comments 

A total of 144 written public 

comments https://osp.od.nih.gov/wpcontent/uploads/2024/10/CompiledPublic-Comments-on-RFI-on-the-NIHDraft-Public-Access-Policy-508C.pdf 

were received in response to the NIH 

Draft Public Access Policy. Written 

comments were received from a variety 


khammond on DSK9W7S144PROD with NOTICES